Junquan Liu

1.4k total citations
37 papers, 678 citations indexed

About

Junquan Liu is a scholar working on Molecular Biology, Biomedical Engineering and Biotechnology. According to data from OpenAlex, Junquan Liu has authored 37 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Biomedical Engineering and 8 papers in Biotechnology. Recurrent topics in Junquan Liu's work include Biofuel production and bioconversion (9 papers), Immune Cell Function and Interaction (7 papers) and Enzyme Production and Characterization (6 papers). Junquan Liu is often cited by papers focused on Biofuel production and bioconversion (9 papers), Immune Cell Function and Interaction (7 papers) and Enzyme Production and Characterization (6 papers). Junquan Liu collaborates with scholars based in China, United States and Pakistan. Junquan Liu's co-authors include Wei Jiang, Abdul Basit, Zhong-Hai Zhou, Fuxing Chen, Huiqiang Lou, Kashif Rahim, Xiaoting Lv, Yongqiang Chen, Lu Zheng and Ting Miao and has published in prestigious journals such as PLoS ONE, Food Chemistry and Free Radical Biology and Medicine.

In The Last Decade

Junquan Liu

37 papers receiving 671 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junquan Liu China 16 305 223 138 97 76 37 678
Junji Morimoto Japan 17 562 1.8× 51 0.2× 114 0.8× 130 1.3× 175 2.3× 55 1.0k
Huijie Jia China 15 269 0.9× 232 1.0× 180 1.3× 110 1.1× 15 0.2× 47 686
Yifeng Zhang China 17 674 2.2× 109 0.5× 46 0.3× 36 0.4× 74 1.0× 66 1.0k
Jingjin He China 14 493 1.6× 136 0.6× 18 0.1× 82 0.8× 78 1.0× 20 895
Dengke Li China 16 369 1.2× 65 0.3× 65 0.5× 38 0.4× 137 1.8× 57 646
Chandan Kanta Das India 13 486 1.6× 51 0.2× 24 0.2× 54 0.6× 69 0.9× 20 816
Zhiyong Xu China 14 254 0.8× 151 0.7× 33 0.2× 100 1.0× 70 0.9× 44 660
Tianyuan Hu China 24 1.5k 4.8× 41 0.2× 66 0.5× 119 1.2× 171 2.3× 101 1.9k
Tong‐Cun Zhang China 16 414 1.4× 31 0.1× 63 0.5× 55 0.6× 85 1.1× 43 810

Countries citing papers authored by Junquan Liu

Since Specialization
Citations

This map shows the geographic impact of Junquan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junquan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junquan Liu more than expected).

Fields of papers citing papers by Junquan Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junquan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junquan Liu. The network helps show where Junquan Liu may publish in the future.

Co-authorship network of co-authors of Junquan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Junquan Liu. A scholar is included among the top collaborators of Junquan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junquan Liu. Junquan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Junquan, Huai-Chin Chiang, Wei Xiong, et al.. (2023). A highly selective humanized DDR1 mAb reverses immune exclusion by disrupting collagen fiber alignment in breast cancer. Journal for ImmunoTherapy of Cancer. 11(6). e006720–e006720. 35 indexed citations
2.
Qiao, Jingbo, Junquan Liu, Rachael A. Clark, et al.. (2022). Anti-GRP-R monoclonal antibody antitumor therapy against neuroblastoma. PLoS ONE. 17(12). e0277956–e0277956. 5 indexed citations
4.
Wang, Yan, Yunpeng Zhang, Jifu Li, et al.. (2021). Novel β-mannanase/GLP-1 fusion peptide high effectively ameliorates obesity in a mouse model by modifying balance of gut microbiota. International Journal of Biological Macromolecules. 191. 753–763. 39 indexed citations
5.
Song, Lina, Abdul Basit, Junquan Liu, et al.. (2020). An endoxylanase rapidly hydrolyzes xylan into major product xylobiose via transglycosylation of xylose to xylotriose or xylotetraose. Carbohydrate Polymers. 237. 116121–116121. 19 indexed citations
6.
Xu, Yifan, Tan Zhang, Yuliang Ma, et al.. (2019). Mesenchymal stem cell sheets: a new cell-based strategy for bone repair and regeneration. Biotechnology Letters. 41(3). 305–318. 52 indexed citations
7.
Geng, Yuanyuan, Jiaojiao Wang, Xi Wang, et al.. (2019). Growth-Inhibitory Effects of Anthracycline-Loaded Bacterial Magnetosomes Against Hepatic Cancer In Vitro and In Vivo. Nanomedicine. 14(13). 1663–1680. 15 indexed citations
8.
Basit, Abdul, Junquan Liu, Kashif Rahim, Wei Jiang, & Huiqiang Lou. (2018). Thermophilic xylanases: from bench to bottle. Critical Reviews in Biotechnology. 38(7). 989–1002. 50 indexed citations
10.
Liu, Junquan, Abdul Basit, Ting Miao, et al.. (2018). Secretory expression of β-mannanase in Saccharomyces cerevisiae and its high efficiency for hydrolysis of mannans to mannooligosaccharides. Applied Microbiology and Biotechnology. 102(23). 10027–10041. 17 indexed citations
11.
Liu, Junquan, et al.. (2018). Insight to Improve α-L-Arabinofuranosidase Productivity in Pichia pastoris and Its Application on Corn Stover Degradation. Frontiers in Microbiology. 9. 3016–3016. 20 indexed citations
12.
Zhang, Yunpeng, Fangfang Guo, Yuanyuan Geng, et al.. (2017). The Disruption of an OxyR-Like Protein Impairs Intracellular Magnetite Biomineralization in Magnetospirillum gryphiswaldense MSR-1. Frontiers in Microbiology. 8. 208–208. 6 indexed citations
13.
Chen, Yongqiang, Lu Zheng, Zhong-Hai Zhou, et al.. (2017). Wnt pathway activator TWS119 enhances the proliferation and cytolytic activity of human γδT cells against colon cancer. Experimental Cell Research. 362(1). 63–71. 24 indexed citations
14.
Chen, Yongqiang, et al.. (2015). [Activation of Wnt/β-catenin pathway in NK cells by glycogen synthase kinase-3β inhibitor TWS119 promotes the expression of CD62L].. PubMed. 31(1). 44–8. 1 indexed citations
15.
Chen, Yongqiang, Lu Zheng, Junquan Liu, et al.. (2014). Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways. International Immunopharmacology. 21(2). 447–455. 77 indexed citations
16.
Wu, Xiaoting, Junquan Liu, Xiaoting Lu, et al.. (2013). The enhanced effect of lupeol on the destruction of gastric cancer cells by NK cells. International Immunopharmacology. 16(2). 332–340. 49 indexed citations
17.
Liu, Gang, Xiaoting Wu, Fuxing Chen, et al.. (2012). The effect of Phloretin on human γδ T cells killing colon cancer SW-1116 cells. International Immunopharmacology. 15(1). 6–14. 23 indexed citations
18.
Hua, Rong, Shanshan Mao, Yong-Mei Zhang, et al.. (2012). Effects of pituitary adenylate cyclase activating polypeptide on CD4+/CD8+T cell levels after traumatic brain injury in a rat model. World Journal of Emergency Medicine. 3(4). 294–294. 10 indexed citations
19.
Liu, Junquan. (2010). Corrosion Failure and Countermeasures of Air Cooler in Atmospheric and Vacuum Distillation Unit. Corrosion & Protection. 1 indexed citations
20.
Chen, Fuxing, Junquan Liu, Guolong Zhang, et al.. (2002). [Clinical observation on adoptive immunotherapy with autologous cytokine-induced killer cells for advanced malignant tumor].. PubMed. 21(7). 797–801. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026